Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares-Reference-Cited by-同舟云学术

Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares

Published:2017-07-09 Issue:11 Volume:18 Page:1115-1125
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Soskind Rose¹,Abazia Daniel T.²³,Bridgeman Mary Barna²⁴

Affiliation:

1. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA

2. Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA

3. Department of Pharmacy, Capital Health Regional Medical Center, Trenton, NJ, USA

4. Department of Pharmacy, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1349099

Reference59 articles.

1. 2016 updated EULAR evidence-based recommendations for the management of gout

2. Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians

3. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008